PBI
69
4
WEC
53
-2
ROST
63
12
UA
50
-9
BA
54
5
PVH
62
5
PLD
56
8
CPB
30
6
NRG
49
-3
EXC
53
-3
VZ
50
3
JWN
48
6
VMC
57
4
KEY
46
3
INTC
33
-2
PG
56
5
TRIP
47
3
CCI
31
3
MTB
67
2
ADBE
49
3
PBI
69
4
WEC
53
-2
ROST
63
12
UA
50
-9
BA
54
5
PVH
62
5
PLD
56
8
CPB
30
6
NRG
49
-3
EXC
53
-3
VZ
50
3
JWN
48
6
VMC
57
4
KEY
46
3
INTC
33
-2
PG
56
5
TRIP
47
3
CCI
31
3
MTB
67
2
ADBE
49
3
Financhill
Back

CollPlant Biotechnologies 10K Form

Sell
41

CLGN
CollPlant Biotechnologies

Last Price:
4.00
Seasonality Move:
49.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLGN News And Ratings

See the #1 stock for the next 7 days that we like better than CLGN

CLGN Financial Statistics

Sales & Book Value

Annual Sales: $10.96M
Cash Flow: $-4.13M
Price / Cash Flow: 0
Annual Sales: $1.81
Price / Book: 2.29

Profitability

EPS (TTM): -1.54000
Net Income (TTM): $-17.47M
Gross Margin: $8.97M
Return on Equity: -61.54%
Return on Assets: -51.35%

CollPlant Biotechnologies Earnings Forecast

Key CollPlant Biotechnologies Financial Ratios

  • The Gross Profit Margin over the past 10 years for CLGN is 81.83%.
  • The Selling, General & Administrative Expenses for CLGN have been equal to 54.71% of Gross Profit Margin.
  • The Research & Development expenses have been 95.67% of Revenue.
  • The Interest Expense is -0.54% of Operating Income.
  • The Net Earning history of CLGN is -64.05% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 4 years.

CollPlant Biotechnologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLGN
CUSIP: 19516Q
Website: collplant.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.27
Quick Ratio: 6.07

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLGN Technical Analysis vs Fundamental Analysis

Sell
41
CollPlant Biotechnologies (CLGN) is a Sell

Is CollPlant Biotechnologies a Buy or a Sell?